Cargando…
Pelvic inflammatory disease: improving awareness, prevention, and treatment
PURPOSE: Pelvic inflammatory disease (PID) is a common disorder of the reproductive tract that is frequently misdiagnosed and inadequately treated. PID and its complications, such as infertility, ectopic pregnancy, and chronic pelvic pain, are preventable by screening asymptomatic patients for sexua...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998032/ https://www.ncbi.nlm.nih.gov/pubmed/27578991 http://dx.doi.org/10.2147/IDR.S91260 |
_version_ | 1782449874539642880 |
---|---|
author | Das, Breanne B Ronda, Jocelyn Trent, Maria |
author_facet | Das, Breanne B Ronda, Jocelyn Trent, Maria |
author_sort | Das, Breanne B |
collection | PubMed |
description | PURPOSE: Pelvic inflammatory disease (PID) is a common disorder of the reproductive tract that is frequently misdiagnosed and inadequately treated. PID and its complications, such as infertility, ectopic pregnancy, and chronic pelvic pain, are preventable by screening asymptomatic patients for sexually transmitted infections (STIs) and promptly treating individuals with STIs and PID. RECENT FINDINGS: The rates of adverse outcomes in women with PID are high and disproportionately affect young minority women. There are key opportunities for prevention including improving provider adherence with national screening guidelines for STIs and PID treatment recommendations and patient medication adherence. Nearly half of all eligible women are not screened for STIs according to national quality standards, which may increase the risk of both acute and subclinical PID. Moreover, in clinical practice, providers poorly adhere to the Centers for Disease Control and Prevention recommendations for treatment of PID. Additionally, patients with PID struggle to adhere to the current management strategies in the outpatient setting. CONCLUSION: Novel evidence-based clinical and public health interventions to further reduce the rates of PID and to improve outcomes for affected women are warranted. We propose potential cost-effective approaches that could be employed in real-world settings. |
format | Online Article Text |
id | pubmed-4998032 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-49980322016-08-30 Pelvic inflammatory disease: improving awareness, prevention, and treatment Das, Breanne B Ronda, Jocelyn Trent, Maria Infect Drug Resist Review PURPOSE: Pelvic inflammatory disease (PID) is a common disorder of the reproductive tract that is frequently misdiagnosed and inadequately treated. PID and its complications, such as infertility, ectopic pregnancy, and chronic pelvic pain, are preventable by screening asymptomatic patients for sexually transmitted infections (STIs) and promptly treating individuals with STIs and PID. RECENT FINDINGS: The rates of adverse outcomes in women with PID are high and disproportionately affect young minority women. There are key opportunities for prevention including improving provider adherence with national screening guidelines for STIs and PID treatment recommendations and patient medication adherence. Nearly half of all eligible women are not screened for STIs according to national quality standards, which may increase the risk of both acute and subclinical PID. Moreover, in clinical practice, providers poorly adhere to the Centers for Disease Control and Prevention recommendations for treatment of PID. Additionally, patients with PID struggle to adhere to the current management strategies in the outpatient setting. CONCLUSION: Novel evidence-based clinical and public health interventions to further reduce the rates of PID and to improve outcomes for affected women are warranted. We propose potential cost-effective approaches that could be employed in real-world settings. Dove Medical Press 2016-08-19 /pmc/articles/PMC4998032/ /pubmed/27578991 http://dx.doi.org/10.2147/IDR.S91260 Text en © 2016 Das et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Das, Breanne B Ronda, Jocelyn Trent, Maria Pelvic inflammatory disease: improving awareness, prevention, and treatment |
title | Pelvic inflammatory disease: improving awareness, prevention, and treatment |
title_full | Pelvic inflammatory disease: improving awareness, prevention, and treatment |
title_fullStr | Pelvic inflammatory disease: improving awareness, prevention, and treatment |
title_full_unstemmed | Pelvic inflammatory disease: improving awareness, prevention, and treatment |
title_short | Pelvic inflammatory disease: improving awareness, prevention, and treatment |
title_sort | pelvic inflammatory disease: improving awareness, prevention, and treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998032/ https://www.ncbi.nlm.nih.gov/pubmed/27578991 http://dx.doi.org/10.2147/IDR.S91260 |
work_keys_str_mv | AT dasbreanneb pelvicinflammatorydiseaseimprovingawarenesspreventionandtreatment AT rondajocelyn pelvicinflammatorydiseaseimprovingawarenesspreventionandtreatment AT trentmaria pelvicinflammatorydiseaseimprovingawarenesspreventionandtreatment |